Lundbeck ready to make acquisitions

Podcast Pharma, Medical & Biotech Public M&A

Danish pharmaceutical company Lundbeck [CPH: LUN] is poised for a run of M&A to replenish its drug pipeline. We caught up with our Nordics reporter, Karoliina Liimatainen, who spoke recently with the company's chief executive, Deborah Dunsire, and has more on the company's plans for growth.

Join My Mergermarket Events

Get exclusive content from our leading M&A and private equity events.

Watch sessions again, download presentations and get exclusive interviews.

Connect with an international community of dealmakers via our event networking app (for attendees only).

Sign Up